The U.S. Food and Drug Administration approved Teflaro (ceftaroline fosamil), an injectable antibiotic to treat adults with community acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI), including…
Tag: virus
Meningitis Warning As Clocks Go Back
With the cold weather set to stay, national charity, the Meningitis Trust, is warning people to stay vigilant to the signs and symptoms of meningitis as cases of the deadly bacterial form…
Scientists identify potential new treatment for Nipah and Hendra viruses
Scientists at Weill Cornell Medical College have identified a potential new treatment for the Nipah and Hendra viruses, two lethal and emerging viruses for which there is currently no treatment or vaccine…
Tenofovir gel to prevent HIV transmission nearing approval
Anti HIV drug Tenofovir in its gel form is to be fast-tracked for approval by the US FDA. The announcement was made by Conrad, a nonprofit scientific organization based in Arlington, Virginia…
Older Patients Surviving Sepsis Infections More Likely To Develop Cognitive Problems
A study of nearly 1,200 older patients hospitalized for severe sepsis indicate that those who survive are at higher risk for long-term cognitive impairment and physical limitations than those hospitalized for other…
Disinfection cap dispensing 70% isopropyl alcohol effectively disinfects IV needleless connectors
A study and review performed by clinicians of PICC Excellence, Inc. found a disinfection cap that dispenses 70% isopropyl alcohol is effective in disinfecting IV needleless connectors after five minutes. The study…
Scripps Florida scientist receives grant from Landenberger Foundation for HIV research
A scientist on the Florida campus of The Scripps Research Institute has received funding from the Philadelphia-based Margaret Q. Landenberger Research Foundation. Susana T. Valente, an assistant professor in the Department of…
Researchers find role of long-non-protein coding RNAs in viral infection
Long, non-protein-coding RNAs may help regulate innate immunity For the first time, scientists have discovered that a poorly understood class of RNA produced in a mammal’s cells during a respiratory virus attack…
Jamieson releases flu-fighting formula with echinacea
FluShield™ provides major breakthrough in immune-boosting natural medicines Jamieson Laboratories, Canada’s largest manufacturer of advanced natural-health products, announced the release of FluShield™, a clinically proven flu-fighting formula that is made with a…
Mundus studies potential for VTOL UAV against Malaria
Mundus Group Inc. (Pink Sheets:MNDP), studies potential for VTOL UAV to provide increased capabilities in fight against Malaria and disease spread through mosquitoes with precision aerial laser eradication treatments. In an effort…
PinPointe FootLaser receives FDA clearance for treatment of nail fungus
The podiatry practice of Mark E. Spier, DPM, announced today that the PinPointe™ FootLaser™ has received clearance from the U.S. Food and Drug Administration (FDA) for the treatment of nail fungus (onychomycosis)….
Survey finds emotional impact of disease greatly affects children
Almost half of children with psoriasis surveyed by the National Psoriasis Foundation report being bullied at least once in the last six months. The Psoriasis Foundation surveyed parents of kids with psoriatic…
Dietary intake of PUFAs associated with decreased prevalence of periodontitis
New study in Journal of the American Dietetic Association indicates link Periodontitis, a common inflammatory disease in which gum tissue separates from teeth, leads to accumulation of bacteria and potential bone and…
Researchers investigate fungal toxin impact on birth defects
A Creighton University School of Medicine researcher has been awarded a $2.7 million grant by the National Institutes of Health (NIH) to investigate a possible link between the ingestion of tortillas and…
Vertex initiates OPTIMIZE Phase 3b study in patients infected with genotype 1 HCV
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the initiation of a Phase 3b study called OPTIMIZE that will evaluate twice-daily (BID) dosing of a telaprevir-based combination regimen in people chronically infected with…